In a drug-eluting stent, drug selection and coating integrity directly influence vascular healing and long-term vessel response. EluNIR-PERL integrates Ridaforolimus with an Elastomeric Coating engineered to support controlled drug release and surface integrity.
Powered by Ridaforolimus
Ridaforolimus is a non-pro-drug analog of rapamycin.
Ridafor...